R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study

  1. Martín, A.
  2. Conde, E.
  3. Arnan, M.
  4. Canales, M.A.
  5. Deben, G.
  6. Sancho, J.M.
  7. Andreu, R.
  8. Salar, A.
  9. García-Sanchez, P.
  10. Vázquez, L.
  11. Nistal, S.
  12. Requena, M.-J.
  13. Donato, E.M.
  14. González, J.A.
  15. León, Á.
  16. Ruiz, C.
  17. Grande, C.
  18. González-Barca, E.
  19. Caballero, M.-D.
Revue:
Haematologica

ISSN: 0390-6078

Année de publication: 2008

Volumen: 93

Número: 12

Pages: 1829-1836

Type: Article

DOI: 10.3324/HAEMATOL.13440 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus